RareStone Group services

The endocrine and metabolic system includes endocrine glands and endocrine tissues, which regulate human function by secreting hormones. Endocrine diseases are rare and often very difficult to diagnose and treat. Among the 121 rare diseases included on China’s national list of rare diseases in 2018, more than 20 are endocrine/metabolic-related rare diseases.

With Zircon Internet+ Hospital, whose scope covers online medical consultation, remote diagnosis and treatment, AI medicine consultation, Doctors are able to make diagnosis and medical advices through on-line image text and image communication or live-talk, without going to the hospital physically.

We`re building a rare disease ecosystem to bring both a support network and much-needed treatments to individuals and their families affected by rare disease. We are developing an integrated platform that can support the scalable commercialization of rare disease drugs in China.

Chronic kidney disease (CKD) is a non-communicable disease usually caused by diabetes and hypertension. The prevalence of chronic kidney disease in China is reported to be 10.8%, and is predicted to increase in the next decade, especially among rural regions and certain geographic regions. Liver disease accounts for approximately 2 million deaths per year worldwide, with 1 million due to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular carcinoma. Specific rare liver and kidney diseases often associated with metabolic syndrome as well as viral hepatitis.